{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:15:34Z","timestamp":1772604934376,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T00:00:00Z","timestamp":1700956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871873"],"award-info":[{"award-number":["81871873"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902334"],"award-info":[{"award-number":["81902334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172872"],"award-info":[{"award-number":["82172872"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010014","name":"Six Talent Peaks Project in Jiangsu Province","doi-asserted-by":"publisher","award":["WSN-039"],"award-info":[{"award-number":["WSN-039"]}],"id":[{"id":"10.13039\/501100010014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010014","name":"Six Talent Peaks Project in Jiangsu Province","doi-asserted-by":"publisher","award":["ZM201921"],"award-info":[{"award-number":["ZM201921"]}],"id":[{"id":"10.13039\/501100010014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.intimp.2023.111286","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T14:19:18Z","timestamp":1701958758000},"page":"111286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A novel transcriptomic signature associated with lymphovascular invasion predicts clinical outcomes, tumor microenvironment, and therapeutic response in lung adenocarcinoma"],"prefix":"10.1016","volume":"127","author":[{"given":"Xing","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yipeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanlin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8397-0318","authenticated-orcid":false,"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziru","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaorong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2023.111286_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.intimp.2023.111286_b0010","first-page":"189","article-title":"Lung cancer: biology and treatment options","volume":"1856","author":"Lemjabbar-Alaoui","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.intimp.2023.111286_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2012.03.031","article-title":"Tumor recurrence after complete resection for non-small cell lung cancer","volume":"93","author":"Taylor","year":"2012","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.intimp.2023.111286_b0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.lungcan.2010.11.013","article-title":"Factors associated with recurrence in patients with curatively resected stage I-II lung cancer","volume":"73","author":"Koo","year":"2011","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2023.111286_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2014.05.070","article-title":"Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer","volume":"98","author":"Lou","year":"2014","journal-title":"Ann. Thorac. Surg."},{"issue":"5","key":"10.1016\/j.intimp.2023.111286_b0030","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.200504-531OE","article-title":"One hundred years of lung cancer","volume":"172","author":"Spiro","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.intimp.2023.111286_b0035","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jtho.2016.06.028","article-title":"The IASLC lung cancer staging project: methodology and validation used in the development of proposals for revision of the stage classification of NSCLC in the forthcoming (Eighth) edition of the TNM classification of lung cancer","volume":"11","author":"Detterbeck","year":"2016","journal-title":"J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2023.111286_b0040","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1096\/fj.01-0945rev","article-title":"The role of tumor lymphangiogenesis in metastatic spread","volume":"16","author":"Stacker","year":"2002","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.intimp.2023.111286_b0045","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.3802\/jgo.2019.30.e84","article-title":"Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish gynecological cancer group study","volume":"30","author":"\u00d8rtoft","year":"2019","journal-title":"J. Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2023.111286_b0050","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41416-019-0486-6","article-title":"A key genomic subtype associated with lymphovascular invasion in invasive breast cancer","volume":"120","author":"Kurozumi","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2023.111286_b0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12967-020-02432-7","article-title":"A novel signature based on microvascular invasion predicts the recurrence of HCC","volume":"18","author":"Du","year":"2020","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.111286_b0060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jtcvs.2018.02.108","article-title":"Prognostic factors including lymphovascular invasion on survival for resected non-small cell lung cancer","volume":"156","author":"Okiror","year":"2018","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.intimp.2023.111286_b0065","doi-asserted-by":"crossref","unstructured":"R. Maeda, J. Yoshida, G. Ishii, T. Hishida, M. Nishimura, K. Nagai, Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification, Chest140(6) (2011) 1494\u20131502.","DOI":"10.1378\/chest.10-3279"},{"issue":"2","key":"10.1016\/j.intimp.2023.111286_b0070","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jtcvs.2013.02.057","article-title":"Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer","volume":"146","author":"Koike","year":"2013","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"10.1016\/j.intimp.2023.111286_b0075","first-page":"612","article-title":"Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke","volume":"13","author":"Sacks","year":"2018","journal-title":"Int. J. Stroke"},{"issue":"17","key":"10.1016\/j.intimp.2023.111286_b0080","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/1759-7714.14530","article-title":"Lymphovascular invasion: a non-sized T descriptor for stage IA non-small cell lung cancer","volume":"13","author":"Cai","year":"2022","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.intimp.2023.111286_b0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.lungcan.2018.09.024","article-title":"Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer","volume":"125","author":"Wang","year":"2018","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"issue":"5","key":"10.1016\/j.intimp.2023.111286_b0090","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.athoracsur.2018.01.032","article-title":"Survival rates after lobectomy, segmentectomy, and wedge resection for non-small cell lung cancer","volume":"105","author":"Cao","year":"2018","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.intimp.2023.111286_b0095","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jtcvs.2014.05.084","article-title":"Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer","volume":"148","author":"Tsutani","year":"2014","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"24","key":"10.1016\/j.intimp.2023.111286_b0100","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/onc.2015.375","article-title":"Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma","volume":"35","author":"Schabath","year":"2016","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.intimp.2023.111286_b0105","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm.1790","article-title":"Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study","volume":"14","author":"Director's Challenge Consortium for the Molecular Classification of Lung A","year":"2008","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.111286_b0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/JTO.0000000000000042","article-title":"Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients","volume":"9","author":"Der","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2023.111286_b0115","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/1078-0432.CCR-12-2321","article-title":"A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients","volume":"19","author":"Tang","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2023.111286_b0120","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1158\/1541-7786.MCR-12-0634-T","article-title":"Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations","volume":"11","author":"Sato","year":"2013","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.111286_b0125","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1158\/1078-0432.CCR-12-1139","article-title":"Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation","volume":"19","author":"Botling","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.111286_b0130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1158\/0008-5472.CAN-11-1403","article-title":"Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas","volume":"72","author":"Okayama","year":"2012","journal-title":"Cancer Res."},{"issue":"186","key":"10.1016\/j.intimp.2023.111286_b0135","doi-asserted-by":"crossref","first-page":"186ra166","DOI":"10.1126\/scitranslmed.3005723","article-title":"Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers","volume":"5","author":"Rousseaux","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.intimp.2023.111286_b0140","doi-asserted-by":"crossref","first-page":"e36530","DOI":"10.1371\/journal.pone.0036530","article-title":"Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation","volume":"7","author":"Wilkerson","year":"2012","journal-title":"PLoS One"},{"issue":"29","key":"10.1016\/j.intimp.2023.111286_b0145","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1200\/JCO.2009.26.4325","article-title":"Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer","volume":"28","author":"Zhu","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.intimp.2023.111286_b0150","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1200\/JCO.2008.19.7053","article-title":"Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis","volume":"27","author":"Tomida","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.intimp.2023.111286_b0155","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1158\/1078-0432.CCR-07-4937","article-title":"Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression","volume":"14","author":"Lee","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.111286_b0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1158\/1078-0432.CCR-12-1139","article-title":"Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation","volume":"19","author":"Botling","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.111286_b0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7150\/ijbs.66536","article-title":"Identification and validation of a prognostic model based on three MVI-related genes in hepatocellular carcinoma","volume":"18","author":"Tang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"D1","key":"10.1016\/j.intimp.2023.111286_b0170","doi-asserted-by":"crossref","first-page":"D900","DOI":"10.1093\/nar\/gky939","article-title":"CancerSEA: a cancer single-cell state atlas","volume":"47","author":"Yuan","year":"2019","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.intimp.2023.111286_b0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinform."},{"issue":"7269","key":"10.1016\/j.intimp.2023.111286_b0180","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2023.111286_b0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.intimp.2023.111286_b0190","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"issue":"11","key":"10.1016\/j.intimp.2023.111286_b0195","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.111286_b0200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med."},{"issue":"4","key":"10.1016\/j.intimp.2023.111286_b0205","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"27","key":"10.1016\/j.intimp.2023.111286_b0210","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.7150\/jca.35489","article-title":"Systematic identification of multi omics-based biomarkers in KEAP1 mutated TCGA lung adenocarcinoma","volume":"10","author":"Namani","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.intimp.2023.111286_b0215","doi-asserted-by":"crossref","first-page":"3583985","DOI":"10.1155\/2022\/3583985","article-title":"Unraveling the expression patterns of immune checkpoints identifies new subtypes and emerging therapeutic indicators in lung adenocarcinoma","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid. Med. Cell Longev"},{"issue":"12","key":"10.1016\/j.intimp.2023.111286_b0220","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.annonc.2020.08.2105","article-title":"KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden","volume":"31","author":"Marinelli","year":"2020","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111286_b0225","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.annonc.2022.12.002","article-title":"Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma","volume":"34","author":"Scalera","year":"2023","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2023.111286_b0230","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/0008-5472.CAN-15-1439","article-title":"STK11\/LKB1 deficiency promotes neutrophil recruitment and proinflammatory cytokine production to suppress t-cell activity in the lung tumor microenvironment","volume":"76","author":"Koyama","year":"2016","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2023.111286_b0235","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jtho.2019.01.011","article-title":"Efficacy of immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer (NSCLC)","volume":"14","author":"Jeanson","year":"2019","journal-title":"J. Thorac. Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2023.111286_b0240","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/2159-8290.CD-18-0099","article-title":"STK11\/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma","volume":"8","author":"Skoulidis","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2023.111286_b0245","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.2147\/OTT.S181432","article-title":"PAQR4 promotes cell proliferation and metastasis through the CDK4-pRB-E2F1 pathway in non-small-cell lung cancer","volume":"12","author":"Wu","year":"2019","journal-title":"Onco. Targets Ther."},{"issue":"3","key":"10.1016\/j.intimp.2023.111286_b0250","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/carcin\/bgx143","article-title":"PAQR4 has a tumorigenic effect in human breast cancers in association with reduced CDK4 degradation","volume":"39","author":"Zhang","year":"2018","journal-title":"Carcinogenesis"},{"issue":"12","key":"10.1016\/j.intimp.2023.111286_b0255","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/abbs\/gmab143","article-title":"PAQR4 promotes the development of hepatocellular carcinoma by activating PI3K\/AKT pathway","volume":"53","author":"Zhao","year":"2021","journal-title":"Acta Biochim. Et Biophys. Sinica"},{"issue":"8","key":"10.1016\/j.intimp.2023.111286_b0260","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.7150\/thno.43142","article-title":"PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation","volume":"10","author":"Xu","year":"2020","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.intimp.2023.111286_b0265","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1182\/blood-2006-07-038703","article-title":"CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms","volume":"109","author":"Zhan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2023.111286_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.582451","article-title":"CKS1B as drug resistance-inducing gene-a potential target to improve cancer therapy","volume":"10","author":"Shi","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2023.111286_b0275","doi-asserted-by":"crossref","first-page":"1052768","DOI":"10.3389\/fimmu.2022.1052768","article-title":"Identification of CKS1B as a prognostic indicator and a predictive marker for immunotherapy in pancreatic cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2023.111286_b0280","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fnmol.2018.00362","article-title":"Loss of ARHGEF6 causes hair cell stereocilia deficits and hearing loss in mice","volume":"11","author":"Zhu","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2023.111286_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106894","article-title":"The pathological significance and potential mechanism of ARHGEF6 in lung adenocarcinoma","volume":"158","author":"Zheng","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.intimp.2023.111286_b0290","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.2147\/CMAR.S248539","article-title":"CFTR functions as a tumor suppressor and is regulated by DNA methylation in colorectal cancer","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"18","key":"10.1016\/j.intimp.2023.111286_b0295","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.intimp.2023.111286_b0300","doi-asserted-by":"crossref","first-page":"e1629258","DOI":"10.1080\/2162402X.2019.1629258","article-title":"High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients","volume":"8","author":"Cao","year":"2019","journal-title":"Oncoimmunology"},{"issue":"6230","key":"10.1016\/j.intimp.2023.111286_b0305","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923016132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923016132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:10:40Z","timestamp":1761588640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923016132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":61,"alternative-id":["S1567576923016132"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111286","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel transcriptomic signature associated with lymphovascular invasion predicts clinical outcomes, tumor microenvironment, and therapeutic response in lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111286"}}